title: The effect of switching from calcineurin inhibitor to sirolimus on the incidence of skin cancers in kidney transplant recipients.
authors.forename: R F
authors.initials: RF
authors.lastname: McQuillan
authors.forename: C M
authors.initials: CM
authors.lastname: O'Seaghdha
authors.forename: A
authors.initials: A
authors.lastname: Bagatto
authors.forename: M
authors.initials: M
authors.lastname: Manusamy
authors.forename: N
authors.initials: N
authors.lastname: Errakiah
authors.forename: C
authors.initials: C
authors.lastname: Sinnott
authors.forename: P
authors.initials: P
authors.lastname: O'Kelly
authors.forename: G M
authors.initials: GM
authors.lastname: Murphy
authors.forename: P J
authors.initials: PJ
authors.lastname: Conlon
mesh_terms: D065095:Calcineurin Inhibitors; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation; D020123:Sirolimus / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000453:epidemiology*
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D020123:Sirolimus